Peter S. Kim, Director at Entrada Therapeutics, Inc. (TRDA), bought 25,000 shares at $14.68 ($367K) on 2024-05-13, disclosed to the SEC on 2025-06-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TRDA | BUY | 2024-04-10 | $35K | — | Filing → |
| TRDA | BUY | 2024-04-01 | $21K | — | Filing → |
| TRDA | BUY | 2024-03-26 | $123K | — | Filing → |